GNC bankruptcy, COVID curb Cardax’s revenue
Biopharmaceutical company Cardax Inc. posted a 71% drop in revenue in the third quarter and said in a regulatory filing Friday that it needs to continue raising capital to avoid curtailing or ceasing its operations.